Clinical Trial Update: Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption [NA]

View source ↗

Summary

This clinical trial update reports on the response of cardiometabolic biomarkers and gut microbiota to walnut consumption in a cardiovascular disease population…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: University of California, Davis | Conditions: Cardiovascular Diseases | NA | Status: ACTIVE_NOT_RECRUITING